The influence of nitric oxide synthase 2 on cutaneous wound angiogenesis

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1223-1235

  Chin, L C ^a   Kumar, P ^a   Palmer, J A ^a   Rophael, J A ^a   Dolderer, J H ^a   Thomas, G P L ^a   Morrison, W A ^a   Penington, A J ^a   Stewart, A G ^a   Mitchell, G M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INDUCIBLE NITRIC OXIDE SYNTHASE; MATRIGEL; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; EXCISION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN INCISION; SKIN INJURY; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; COLLAGEN; DRUG COMBINATIONS; FIBROBLAST GROWTH FACTOR 2; ISCHEMIA; LAMININ; MICE; NITRIC OXIDE SYNTHASE TYPE II; PROTEOGLYCANS; SKIN; SURGICAL FLAPS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 82255186744     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10599.x     Document Type: Article

References (48)

1. Kalluri R,. Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 2003; 3: 422-33. (Pubitemid 37328846)
2. Battegay E,. [Angiogenesis-mechanisms and therapeutic approaches]. Schweiz Rundsch Med Prax 1995; 84: 118-21.
3. Battegay EJ,. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995; 73: 333-46.
4. Gale NW, Yancopoulos GD,. Growth factors acting via endothelial cell-specific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 1999; 13: 1055-66. (Pubitemid 29233137)
5. Brekken RA, Overholser JP, Stastny VA, et al. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res 2000; 60: 5117-24.
6. Akimoto S, Ishikawa O, Iijima C, Miyachi Y,. Expression of basic fibroblast growth factor and its receptor by fibroblast, macrophages and mast cells in hypertrophic scar. Eur J Dermatol 1999; 9: 357-62. (Pubitemid 29366883)
7. Forstermann U, Gath I, Schwarz P, et al. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control. Biochem Pharmacol 1995; 50: 1321-32.
8. Bussolati B, Dunk C, Grohman M, et al. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide. Am J Pathol 2001; 159: 993-1008. (Pubitemid 32847190)
9. Ziche M, Morbidelli L, Masini E, et al. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 1993; 192: 1198-203. (Pubitemid 23218541)
10. Ziche M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036-44. (Pubitemid 24348244)
11. Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 1997; 99: 2625-34. (Pubitemid 27259809)
12. Kimura H, Esumi H,. Reciprocal regulation between nitric oxide and vascular endothelial growth factor in angiogenesis. Acta Biochim Pol 2003; 50: 49-59. (Pubitemid 37034227)
13. Morbidelli L, Donnini S, Ziche M,. Role of nitric oxide in the modulation of angiogenesis. Curr Pharm Des 2003; 9: 521-30. (Pubitemid 36221720)
14. Ziche M, Morbidelli L,. Nitric oxide and angiogenesis. J Neurooncol 2000; 50: 139-48. (Pubitemid 32166296)
15. Ozel E, Pestereli HE, Simsek T, et al. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in ovarian surface epithelial carcinomas: is there any correlation with angiogenesis or clinicopathologic parameters? Int J Gynecol Cancer 2006; 16: 549-55.
16. Mazibrada J, Ritta M, Mondini M, et al. Interaction between inflammation and angiogenesis during different stages of cervical carcinogenesis. Gynecol Oncol 2008; 108: 112-20. (Pubitemid 350299432)
17. Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998; 90: 587-96. (Pubitemid 28204802)
18. Franchi A, Gallo O, Paglierani M, et al. Inducible nitric oxide synthase expression in laryngeal neoplasia: correlation with angiogenesis. Head Neck 2002; 24: 16-23. (Pubitemid 34013850)
19. Niu XJ, Wang ZR, Wu SL, et al. Relationship between inducible nitric oxide synthase expression and angiogenesis in primary gallbladder carcinoma tissue. World J Gastroenterol 2004; 10: 725-8.
20. Chen CN, Hsieh FJ, Cheng YM, et al. Expression of inducible nitric oxide synthase and cyclooxygenase-2 in angiogenesis and clinical outcome of human gastric cancer. J Surg Oncol 2006; 94: 226-33.
21. Lin Z, Chen S, Ye C, et al. Nitric oxide synthase expression in human bladder cancer and its relation to angiogenesis. Urol Res 2003; 31: 232-5. (Pubitemid 37122166)
22. Cianchi F, Cortesini C, Fantappie O, et al. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. Am J Pathol 2003; 162: 793-801. (Pubitemid 36237488)
23. Cullis ER, Kalber TL, Ashton SE, et al. Tumour overexpression of inducible nitric oxide synthase (iNOS) increases angiogenesis and may modulate the anti-tumour effects of the vascular disrupting agent ZD6126. Microvasc Res 2006; 71: 76-84.
24. Massi D, De Nisi MC, Franchi A, et al. Inducible nitric oxide synthase expression in melanoma: implications in lymphangiogenesis. Mod Pathol 2009; 22: 21-30.
25. Kostourou V, Cartwright JE, Johnstone AP, et al. The role of tumour-derived iNOS in tumour progression and angiogenesis. Br J Cancer 2011; 104: 83-90.
26. Zhang W, He XJ, Ma YY, et al. Inducible nitric oxide synthase expression correlates with angiogenesis, lymphangiogenesis, and poor prognosis in gastric cancer patients. Hum Pathol 2011; 42: 1275-82.
27. Engels K, du Bois A, Harter P, et al. VEGF-A and i-NOS expression are prognostic factors in serous epithelial ovarian carcinomas after complete surgical resection. J Clin Pathol 2009; 62: 448-54.
28. Glynn SA, Boersma BJ, Dorsey TH, et al. Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients. J Clin Invest 2010; 120: 3843-54.
29. Nakagawa SA, Lopes A, Lopes de Carvalho A, et al. Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis. J Bone Joint Surg Am 2010; 92: 1738-46.
30. Konopka TE, Barker JE, Bamford TL, et al. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production. Cancer Res 2001; 61: 3182-7. (Pubitemid 32691973)
31. Stallmayer B, Kampfer H, Kolb N, et al. The function of nitric oxide in wound repair: inhibition of inducible nitric oxide-synthase severely impairs wound reepithelialization. J Invest Dermatol 1999; 113: 1090-8. (Pubitemid 30013358)
32. Frank S, Stallmeyer B, Kampfer H, et al. Nitric oxide triggers induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair. FASEB J 1999; 13: 2002-14. (Pubitemid 29517630)
33. Luo JD, Chen AF,. Nitric oxide: a newly discovered function on wound healing. Acta Pharmacol Sin 2005; 26: 259-64. (Pubitemid 40388060)
34. Yamasaki K, Edington HD, McClosky C, et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998; 101: 967-71. (Pubitemid 28125274)
35. Most D, Efron DT, Shi HP, et al. Characterization of incisional wound healing in inducible nitric oxide synthase knockout mice. Surgery 2002; 132: 866-76. (Pubitemid 36307826)
36. Kane AJ, Barker JE, Mitchell GM, et al. Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival. Br J Pharmacol 2001; 132: 1631-8. (Pubitemid 32397954)
37. Furuta S, Vadiveloo P, Romeo-Meeuw R, et al. Early inducible nitric oxide synthase 2 (NOS 2) activity enhances ischaemic skin flap survival. Angiogenesis 2004; 7: 33-43. (Pubitemid 39127769)
38. Howdieshell TR, Webb WL, Sathyanarayana, McNeil PL,. Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion. Surgery 2003; 133: 528-37. (Pubitemid 36638225)
39. Dudar GK, D'Andrea LD, Di Stasi R, et al. A vascular endothelial growth factor mimetic accelerates gastric ulcer healing in an iNOS-dependent manner. Am J Physiol Gastrointest Liver Physiol 2008; 295: G374-81.
40. Lokmic Z, Darby IA, Thompson EW, et al. A time course analysis of hypoxia, granulation tissue and blood vessel growth and remodelling in healing rat cutaneous incisional primary intention wounds. Wound Repair Regen 2006; 14: 277-88. (Pubitemid 43979257)
41. MacSween RMN, Whaley K, (eds). Muir's Textbook of Pathology, 13th edn. London: Hodder and Stoughton, 1992; Chapter 4.
42. Howard CV, Reed MG,. Unbiased Stereology. Three-Dimensional Measurement in Microscopy. Oxford: BIOS Scientific Publishers, 1998.
43. Gosain A, Matthies AM, Dovi JV, et al. Exogenous pro-angiogenic stimuli cannot prevent physiologic vessel regression. J Surg Res 2006; 135: 218-25. (Pubitemid 44414889)
44. Heffernan D, Dudley B, McNeil PL, et al. Local arginine supplementation results in sustained wound nitric oxide production and reductions in vascular endothelial growth factor expression and granulation tissue formation. J Surg Res 2006; 133: 46-54.
45. Thornton FJ, Schaffer MR, Witte MB, et al. Enhanced collagen accumulation following direct transfection of the inducible nitric oxide synthase gene in cutaneous wounds. Biochem Biophys Res Commun 1998; 246: 654-9. (Pubitemid 28420914)
46. Hsu YC, Hsiao M, Wang LF, et al. Nitric oxide produced by iNOS is associated with collagen synthesis in keloid scar formation. Nitric Oxide 2006; 14: 327-34. (Pubitemid 43816315)
47. Witte MB, Thornton FJ, Tantry U, et al. l-Arginine supplementation enhances diabetic wound healing: involvement of the nitric oxide synthase and arginase pathways. Metabolism 2002; 51: 1269-73. (Pubitemid 35174147)
48. Sappayatosok K, Maneerat Y, Swasdison S, et al. Expression of pro-inflammatory protein, iNOS, VEGF and COX-2 in oral squamous cell carcinoma (OSCC), relationship with angiogenesis and their clinico-pathological correlation. Med Oral Patol Oral Cir Bucal 2009; 14: E319-24.